Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lasix for Prevention of De Novo Postpartum Hypertension
NCT04752475Phase 3Completed
- Sponsor
- Columbia University
- Start
- Oct 2021
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypertension (HTN) comparing Lasix (furosemide) with Placebo (2 arms). Primary endpoint: Mean Arterial Blood Pressure. Started Oct 2021; status: completed.
02
Drugs
furosemide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT04752475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04752475.